{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:53:04Z","timestamp":1784209984467,"version":"3.55.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.cld.2016.08.008","type":"journal-article","created":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T17:18:13Z","timestamp":1476638293000},"page":"103-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Drug Hepatotoxicity"],"prefix":"10.1016","volume":"21","author":[{"given":"Jonathan G.","family":"Stine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naga P.","family":"Chalasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cld.2016.08.008_bib1","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","article-title":"Drug-induced acute liver failure: results of a U.S. multicenter, prospective study","volume":"52","author":"Reuben","year":"2010","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2016.08.008_bib2","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/00365520510023846","article-title":"Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden","volume":"40","author":"Bjornsson","year":"2005","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2016.08.008_bib3","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.cld.2016.08.008_bib4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425255.2011.577415","article-title":"Drug-induced liver injury: a summary of recent advances","volume":"7","author":"Stine","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"10.1016\/j.cld.2016.08.008_bib5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.cld.2016.08.008_bib6","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ajg.2014.131","article-title":"ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury","volume":"109","author":"Chalasani","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.cld.2016.08.008_bib7","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1111\/liv.12958","article-title":"Chronic liver injury induced by drugs: a systematic review","volume":"35","author":"Stine","year":"2015","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2014.03.045","article-title":"Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6\u00a0months from onset","volume":"147","author":"Fontana","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1440-1746.2012.07279.x","article-title":"Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury","volume":"28","author":"Devarbhavi","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2016.08.008_bib10","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1038\/ajg.2010.287","article-title":"Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality","volume":"105","author":"Devarbhavi","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2016.08.008_bib11","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 889 patients with drug-induced liver injury: the DILIN prospective study","volume":"48","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.08.008_bib12","series-title":"Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver","author":"Zimmerman","year":"1999"},{"key":"10.1016\/j.cld.2016.08.008_bib13","series-title":"Drug-induced liver disease","first-page":"746","year":"2013"},{"key":"10.1016\/j.cld.2016.08.008_bib14","unstructured":"FDA drug stopping rules 2009. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/\u2026\/Guidances\/UCM174090.pdf. Accessed April 11, 2016."},{"issue":"12","key":"10.1016\/j.cld.2016.08.008_bib15","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.cgh.2015.06.017","article-title":"The art and science of diagnosing and managing drug-induced liver injury in 2015 and beyond","volume":"13","author":"Lewis","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2016.08.008_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/009286150804200501","article-title":"VigiBase, the WHO global ICSR database system: basic facts","volume":"42","author":"Lindquist","year":"2007","journal-title":"Drug Inform J"},{"issue":"12","key":"10.1016\/j.cld.2016.08.008_bib17","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/BF03262002","article-title":"Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase","volume":"35","author":"Aagaard","year":"2012","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.cld.2016.08.008_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40264-015-0387-4","article-title":"Adverse drug reaction reporting in Africa and a comparison of individual case safety report characteristics between Africa and the rest of the world: analyses of spontaneous reports in vigiBase((R))","volume":"39","author":"Ampadu","year":"2016","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.cld.2016.08.008_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2165\/11535340-000000000-00000","article-title":"Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work","volume":"33","author":"Suzuki","year":"2010","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.cld.2016.08.008_bib20","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1053\/jhep.2002.32148","article-title":"Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity","volume":"35","author":"Schmidt","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2016.08.008_bib21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00004836-198704000-00014","article-title":"Hepatic effects of acetaminophen. Enhanced toxicity in alcoholics","volume":"9","author":"Maddrey","year":"1987","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2016.08.008_bib22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/hep.1840220312","article-title":"Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure","volume":"22","author":"Zimmerman","year":"1995","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3810\/pgm.2000.01.831","article-title":"Alcohol-acetaminophen syndrome. Even moderate social drinkers are at risk","volume":"107","author":"Draganov","year":"2000","journal-title":"Postgrad Med"},{"issue":"3","key":"10.1016\/j.cld.2016.08.008_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7326\/0003-4819-104-3-399","article-title":"Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure","volume":"104","author":"Seeff","year":"1986","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3565(25)21438-0","article-title":"Ethanol suppresses hepatic glutathione synthesis in rats in\u00a0vivo","volume":"230","author":"Lauterburg","year":"1984","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"9","key":"10.1016\/j.cld.2016.08.008_bib26","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/gut.29.9.1153","article-title":"Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity","volume":"29","author":"Lauterburg","year":"1988","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cld.2016.08.008_bib27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/096032719101000612","article-title":"The effect of chronic alcohol intake on prognosis and outcome in paracetamol overdose","volume":"10","author":"Bray","year":"1991","journal-title":"Hum Exp Toxicol"},{"issue":"2","key":"10.1016\/j.cld.2016.08.008_bib28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/2249-4863.154661","article-title":"Drug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients","volume":"4","author":"Gaude","year":"2015","journal-title":"J\u00a0Family Med Prim Care"},{"issue":"4","key":"10.1016\/j.cld.2016.08.008_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1530-0277.1984.tb05688.x","article-title":"Interaction of acute ethanol administration with acetaminophen metabolism and toxicity in rats fed alcohol chronically","volume":"8","author":"Altomare","year":"1984","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1016\/j.cld.2016.08.008_bib30","first-page":"229","article-title":"Focus on the liver: alcohol use, highly active antiretroviral therapy, and liver disease in HIV-infected patients","volume":"33","author":"Barve","year":"2010","journal-title":"Alcohol Res Health"},{"issue":"11","key":"10.1016\/j.cld.2016.08.008_bib31","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1517\/17425255.2012.714366","article-title":"Alcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes","volume":"8","author":"Kumar","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"10.1016\/j.cld.2016.08.008_bib32","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s10620-014-3422-x","article-title":"Hepatic decompensation likely attributable to simeprevir in patients with advanced cirrhosis","volume":"60","author":"Stine","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.cld.2016.08.008_bib33","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0168-8278(98)80341-3","article-title":"Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users","volume":"28","author":"Pol","year":"1998","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/341084","article-title":"Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy","volume":"186","author":"Wit","year":"2002","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.cld.2016.08.008_bib35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1155\/1996\/213596","article-title":"Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up","volume":"10","author":"Malatjalian","year":"1996","journal-title":"Can J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2016.08.008_bib36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0002-9343(05)80060-9","article-title":"Methotrexate and histologic hepatic abnormalities: a meta-analysis","volume":"90","author":"Whiting-O'Keefe","year":"1991","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.cld.2016.08.008_bib37","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/hep.21424","article-title":"Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry","volume":"44","author":"Andrade","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2016.08.008_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tube.2014.03.006","article-title":"The role of cigarette smoking and liver enzymes polymorphisms in anti-tuberculosis drug-induced hepatotoxicity in Brazilian patients","volume":"94","author":"Zaverucha-do-Valle","year":"2014","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00204-004-0607-7","article-title":"Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta","volume":"79","author":"Czekaj","year":"2005","journal-title":"Arch Toxicol"},{"issue":"4","key":"10.1016\/j.cld.2016.08.008_bib40","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.20445","article-title":"Drug-induced liver injury network (DILIN)","volume":"40","author":"Hoofnagle","year":"2004","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2016.08.008_bib41","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1046\/j.1365-2036.2003.01789.x","article-title":"The impact of current tobacco use on the outcome of paracetamol poisoning","volume":"18","author":"Schmidt","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.cld.2016.08.008_bib42","first-page":"521","article-title":"Risk factor of liver disorders caused by flutamide\u2013statistical analysis using multivariate logistic regression analysis","volume":"45","author":"Wada","year":"1999","journal-title":"Hinyokika Kiyo"},{"issue":"11","key":"10.1016\/j.cld.2016.08.008_bib43","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.3390\/ijms11114697","article-title":"Comparison of TNFalpha to lipopolysaccharide as an inflammagen to characterize the idiosyncratic hepatotoxicity potential of drugs: trovafloxacin as an example","volume":"11","author":"Liguori","year":"2010","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/toxsci\/kfq168","article-title":"Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity","volume":"118","author":"Shaw","year":"2010","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/15287390903249057","article-title":"Bacterial- and viral-induced inflammation increases sensitivity to acetaminophen hepatotoxicity","volume":"73","author":"Maddox","year":"2010","journal-title":"J\u00a0Toxicol Environ Health A"},{"issue":"4","key":"10.1016\/j.cld.2016.08.008_bib46","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/hep.21779","article-title":"Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice","volume":"46","author":"Ganey","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2016.08.008_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0300-483X(00)00193-1","article-title":"Endotoxin pretreatment protects against the hepatotoxicity of acetaminophen and carbon tetrachloride: role of cytochrome P450 suppression","volume":"147","author":"Liu","year":"2000","journal-title":"Toxicology"},{"issue":"14","key":"10.1016\/j.cld.2016.08.008_bib48","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/00984100290071252","article-title":"Endotoxin potentiates the hepatotoxicity of cocaine in male mice","volume":"65","author":"Labib","year":"2002","journal-title":"J\u00a0Toxicol Environ Health A"},{"issue":"12","key":"10.1016\/j.cld.2016.08.008_bib49","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/apt.12324","article-title":"Review article: prescribing medications in patients with cirrhosis - a practical guide","volume":"37","author":"Lewis","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib50","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/toxsci\/kfr266","article-title":"Amiodarone exposure during modest inflammation induces idiosyncrasy-like liver injury in rats: role of tumor necrosis factor-alpha","volume":"125","author":"Lu","year":"2012","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib51","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/jpet.109.156331","article-title":"Sulindac metabolism and synergy with tumor necrosis factor-alpha in a drug-inflammation interaction model of idiosyncratic liver injury","volume":"331","author":"Zou","year":"2009","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/toxsci\/kfm209","article-title":"The role of tumor necrosis factor alpha in lipopolysaccharide\/ranitidine-induced inflammatory liver injury","volume":"100","author":"Tukov","year":"2007","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/hep.22585","article-title":"Effect of polyI: C cotreatment on halothane-induced liver injury in mice","volume":"49","author":"Cheng","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2016.08.008_bib54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.taap.2009.01.018","article-title":"The role of the hemostatic system in murine liver injury induced by coexposure to lipopolysaccharide and trovafloxacin, a drug with idiosyncratic liability","volume":"236","author":"Shaw","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.26510","article-title":"Prothrombotic factors in histologically proven NAFLD and NASH","volume":"59","author":"Verrijken","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2016.08.008_bib56","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/hep.20492","article-title":"Role of hepatic fibrin in idiosyncrasy-like liver injury from lipopolysaccharide-ranitidine coexposure in rats","volume":"40","author":"Luyendyk","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib57","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/hep.26307","article-title":"Role of procoagulant microparticles in mediating complications and outcome of acute liver injury\/acute liver failure","volume":"58","author":"Stravitz","year":"2013","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2016.08.008_bib58","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3109\/07420528.2015.1078808","article-title":"Circadian variation in murine hepatotoxicity to the antituberculosis agent <<Isoniazide>>","volume":"32","author":"Souayed","year":"2015","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.cld.2016.08.008_bib59","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.pharmtox.47.120505.105208","article-title":"Circadian rhythms: mechanisms and therapeutic implications","volume":"47","author":"Levi","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.cld.2016.08.008_bib60","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0748730414544740","article-title":"The hepatic circadian clock modulates xenobiotic metabolism in mice","volume":"29","author":"DeBruyne","year":"2014","journal-title":"J\u00a0Biol Rhythms"},{"issue":"52","key":"10.1016\/j.cld.2016.08.008_bib61","doi-asserted-by":"crossref","first-page":"18757","DOI":"10.1073\/pnas.1421708111","article-title":"Hepatocyte circadian clock controls acetaminophen bioactivation through NADPH-cytochrome P450 oxidoreductase","volume":"111","author":"Johnson","year":"2014","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2\u20133","key":"10.1016\/j.cld.2016.08.008_bib62","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tox.2013.09.009","article-title":"Deletion of circadian gene Per1 alleviates acute ethanol-induced hepatotoxicity in mice","volume":"314","author":"Wang","year":"2013","journal-title":"Toxicology"},{"issue":"8","key":"10.1016\/j.cld.2016.08.008_bib63","doi-asserted-by":"crossref","first-page":"e44237","DOI":"10.1371\/journal.pone.0044237","article-title":"Diurnal variation of hepatic antioxidant gene expression in mice","volume":"7","author":"Xu","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cld.2016.08.008_bib64","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.etp.2010.04.011","article-title":"Clock gene mPer2 functions in diurnal variation of acetaminophen induced hepatotoxicity in mice","volume":"63","author":"Kakan","year":"2011","journal-title":"Exp Toxicol Pathol"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib65","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/toxsci\/kfi166","article-title":"Hepatic gene expression changes throughout the day in the Fischer rat: implications for toxicogenomic experiments","volume":"86","author":"Boorman","year":"2005","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1124\/jpet.300.1.273","article-title":"Mechanisms of circadian rhythmicity of carbon tetrachloride hepatotoxicity","volume":"300","author":"Bruckner","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.cld.2016.08.008_bib67","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1515\/DMDI.1994.11.4.317","article-title":"Circadian rhythms of paracetamol metabolism in healthy subjects; a preliminary report","volume":"11","author":"Ngong","year":"1994","journal-title":"Drug Metabol Drug Interact"},{"issue":"3","key":"10.1016\/j.cld.2016.08.008_bib68","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0041-008X(83)90022-4","article-title":"Circadian rhythm in acetaminophen toxicity: role of nonprotein sulfhydryls","volume":"71","author":"Schnell","year":"1983","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib69","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0378-4274(91)90121-L","article-title":"Circadian variation of hepatic UDP-glucuronic acid and the glucuronidation of xenobiotics in mice","volume":"57","author":"Howell","year":"1991","journal-title":"Toxicol Lett"},{"issue":"2","key":"10.1016\/j.cld.2016.08.008_bib70","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0026-0495(86)90110-1","article-title":"The effect of fasting on leukocyte and plasma glutathione and sulfur amino acid concentrations","volume":"35","author":"Martensson","year":"1986","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib71","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00003088-199631010-00004","article-title":"Influence of diet and nutritional status on drug metabolism","volume":"31","author":"Walter-Sack","year":"1996","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"10.1016\/j.cld.2016.08.008_bib72","first-page":"299","article-title":"Isoniazid pharmacokinetics in kwashiorkor","volume":"56","author":"Buchanan","year":"1979","journal-title":"S\u00a0Afr Med J"},{"issue":"3","key":"10.1016\/j.cld.2016.08.008_bib73","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/liv.12689","article-title":"The role of intestinal microbiota in murine models of acetaminophen-induced hepatotoxicity","volume":"35","author":"Possamai","year":"2015","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.cld.2016.08.008_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00498254.2016.1140847","article-title":"3,4-Dihydroxyphenylacetic acid, a microbiota-derived metabolite of quercetin, attenuates acetaminophen (APAP)-induced liver injury through activation of Nrf-2","volume":"46","author":"Xue","year":"2016","journal-title":"Xenobiotica"},{"issue":"11","key":"10.1016\/j.cld.2016.08.008_bib75","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s12272-012-1114-7","article-title":"Alteration of bile acid metabolism in pseudo germ-free rats [corrected]","volume":"35","author":"Bhowmik","year":"2012","journal-title":"Arch Pharm Res"},{"issue":"11","key":"10.1016\/j.cld.2016.08.008_bib76","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.amjmed.2013.05.014","article-title":"Health consequences among subjects involved in Gulf oil spill clean-up activities","volume":"126","author":"D'Andrea","year":"2013","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.cld.2016.08.008_bib77","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19338244.2011.564230","article-title":"Effect of chronic pesticide exposure in farm workers of a Mexico community","volume":"67","author":"Payan-Renteria","year":"2012","journal-title":"Arch Environ Occup Health"},{"issue":"1\u20132","key":"10.1016\/j.cld.2016.08.008_bib78","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/03602530600569984","article-title":"Organophosphorus chemicals: potent inhibitors of the human metabolism of steroid hormones and xenobiotics","volume":"38","author":"Hodgson","year":"2006","journal-title":"Drug Metab Rev"},{"issue":"4","key":"10.1016\/j.cld.2016.08.008_bib79","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jbt.20175","article-title":"Human metabolic interactions of environmental chemicals","volume":"21","author":"Hodgson","year":"2007","journal-title":"J\u00a0Biochem Mol Toxicol"},{"issue":"5","key":"10.1016\/j.cld.2016.08.008_bib80","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1007\/s11356-014-3620-2","article-title":"Hepatotoxicity and nephrotoxicity of organic contaminants in wastewater-irrigated soil","volume":"22","author":"Gao","year":"2015","journal-title":"Environ Sci Pollut Res Int"},{"key":"10.1016\/j.cld.2016.08.008_bib81","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ecoenv.2012.03.008","article-title":"Environmental exposure to organophosphate pesticides: assessment of endocrine disruption and hepatotoxicity in pregnant women","volume":"80","author":"Cecchi","year":"2012","journal-title":"Ecotoxicol Environ Saf"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326116300678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326116300678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T14:32:56Z","timestamp":1749652376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326116300678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1089326116300678"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2016.08.008","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug Hepatotoxicity","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2016.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}